Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052
Disclosure according to Article 5 of the EU Regulation 596/2014 and Article 2 Section (1) of the Delegated EU Regulation 2016/1052
In the period from June 21 up to and including June 24, 2021, a total of 3.240 shares of AlzChem Group AG were acquired as part of the share buyback program announced on February 2, 2021. The total number of shares acquired to date as part of this buyback amounts to 40.581. The acquisition was carried out by ODDO BHF Aktiengesellschaft, Frankfurt am Main/Germany via the stock exchange (XETRA) on behalf of AlzChem Group AG.
The total number of repurchased shares in the last week, the weighted average price and the aggregated volume per day were as follows:
| Buyback date | Total number of shares | Weighted average price (EUR) | Aggregated volume (EUR) |
|---|---|---|---|
| 21.06.2021 | 672 | 25,1000 | 16.867,20 |
| 22.06.2021 | 926 | 25,0000 | 23.150,00 |
| 23.06.2021 | 935 | 25,0000 | 23.375,00 |
| 24.06.2021 | 707 | 25,0000 | 17.675,00 |
| Σ | 3.240 | 25,0207 | 81.067,20 |
With the share buyback on June 24, 2021, the budget allocated for this purpose has been exhausted; the share buyback program is therefore complete. The number of shares repurchased during the entire share buyback program, the weighted average price and the aggregate volume were as follows:
| Trading period | Total number of shares | Weighted average price (EUR) | Aggregated volume (EUR) |
|---|---|---|---|
| 08.02. - 24.06.2021 | 40.581 | 24,6416 | 999.979,90 |
This information as well as the detailed information on the individual daily transactions related to the buy-back program are also published on the Company's website at https://www.alzchem.com/de/investor-relations/stock/share-buy-back in accordance with Art. 2 par. 3 sentence 2 of Delegated Regulation (EU) 2016/1052.
Trostberg, June 28, 2021
AlzChem Group AG
About AlzChem
AlzChem is a globally active specialty chemicals company that is predominantly among the market leaders in its fields of activity. AlzChem benefits in particular from the three very different global developments of climate change, population growth and longer life expectancy. In order to achieve the resulting social goals, AlzChem products can offer attractive solutions with a wide range of different applications.
The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. AlzChem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective.
The broad product range of AlzChem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company’s response to global trends and developments. AlzChem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments.
The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.
Contact
Sabine Sieber
Head of Investor Relations & Communications
Alzchem Group AG
Dr.-Albert-Frank-Str. 32
83308 Trostberg
Germany